Analysis of the HVTN 702 Phase 2b-3 HIV-1 vaccine trial in South Africa assessing RV144 antibody and T cell correlates of HIV-1 acquisition risk
Z. Moodie,S. Sawant, O. Dintwe,D. Grove,Y. Huang,H. Janes, J. Heptinstall,F. Laher Omar,K. Cohen,S. C. De Rosa, L. Zhang,N. L. Yates,M. Sarzotti-Kelsoe,K. E. Seaton,F. Laher,L. -G. Bekker,M. Malahleha,C. Innes,S. Kassim,N. Naicker,V. Govender, M. Sebe,N. Singh, P. Kotze,E. Lazarus,M. Nchabeleng, A. M. Ward,W. Brumskine, T. Dubula,A. K. Randhawa,N. Grunenberg,J. Jin Kee,L. N. Carpp, J. Hural,M. Allen,P. D'Souza,J. Tartaglia,C. A. DiazGranados,M. Koutsoukos,P. B. Gilbert,J. G. Kublin,L. Corey,E. Andersen-Nissen,G. E. Gray,G. D. Tomaras,M. J. McElrath JOURNAL OF THE INTERNATIONAL AIDS SOCIETY（2022）
AI 理解论文
溯源树
样例
